PERCEPTIVE ADVISORS LLC

13F Portfolio Filings

Most recent 13F
Q3 2026
Location
New York, NY
CIK
0001224962
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2026 108 5,340,358 PRAX, AMLX, SYRE, MRNA puts 13F-HR 11/16/2026 000101297526001063
Q2 2026 109 6,440,507 PRAX, SYRE, CELC, ASND 13F-HR 8/14/2026 000101297526000777
Q1 2026 94 5,062,540 PRAX, CELC, ASND, ROIV RESTATEMENT 5/29/2026 000101297526000499
Q4 2025 116 5,458,314 PRAX, CELC, RYTM, ASND 13F-HR 2/17/2026 000101297526000155
Q3 2025 93 3,461,089 RYTM, ASND, ACLX, CELC 13F-HR 11/14/2025 000101297525000762
Q2 2025 85 2,665,032 VRNA, ASND, ACLX, RYTM 13F-HR 8/14/2025 000101297525000446
Q1 2025 87 2,819,734 VRNA, ACLX, FOLD, EWTX RESTATEMENT 8/6/2025 000101297525000422
Q4 2024 99 3,589,386 VRNA, ACLX, FOLD, RYTM 13F-HR 2/14/2025 000101297525000090
Q3 2024 108 4,660,827 ACLX, NUVL, FOLD, IOVA 13F-HR 11/14/2024 000101297524000488
Q2 2024 110 4,142,981 CERE, FOLD, ACLX, IOVA RESTATEMENT 8/16/2024 000101297524000346
Q1 2024 112 5,674,408 CERE, FOLD, IOVA, ACLX RESTATEMENT 8/6/2024 000101297524000315
Q4 2023 101 4,473,418 CERE, FOLD, LIANY, ACLX RESTATEMENT 2/26/2024 000101297524000112
Q3 2023 97 2,974,400 FOLD, CERE, IMVT, ACLX 13F-HR 11/14/2023 000101297523000471
Q2 2023 95 3,441,820 FOLD, CERE, LIANY, ACLX RESTATEMENT 8/24/2023 000101297523000365
Q1 2023 99 3,379,384 FOLD, RETA, AMLX, CERE RESTATEMENT 5/16/2023 000101297523000242
Q4 2022 96 3,469,674 FOLD, AMLX, MDGL, CERE 13F-HR 2/14/2023 000101297523000099
Q3 2022 116 3,440,420 FOLD, MRTX, CERE, GBT 13F-HR 11/14/2022 000101297522000502
Q2 2022 111 3,182,573 TRAVERE THERAPEUTICS INC, FOLD, MRTX, CERE 13F-HR 8/15/2022 000101297522000365
Q1 2022 135 4,992,282 TRAVERE THERAPEUTICS INC, FOLD, SWTX, LIANY 13F-HR 5/16/2022 000101297522000241
Q4 2021 147 6,473,647 TRAVERE THERAPEUTICS INC, MRTX, LIANY, FOLD NEW HOLDINGS 5/4/2022 000101297522000209
Q3 2021 140 6,862,444 MRTX, TRAVERE THERAPEUTICS INC, BBIO, SWTX RESTATEMENT 12/3/2021 000101297521000492
Q2 2021 150 7,689,600 MRTX, BBIO, SWTX, RETROPHIN INC NEW HOLDINGS 8/17/2021 000101297521000326
Q1 2021 139 7,523,692 MRTX, BBIO, RETROPHIN INC, SWTX RESTATEMENT 8/13/2021 000101297521000299
Q4 2020 139 9,276,837 MRTX, FOLD, BBIO, RETROPHIN INC 13F-HR 2/16/2021 000101297521000086
Q3 2020 126 6,786,487 MRTX, RETROPHIN INC, FOLD, IOVA 13F-HR 11/16/2020 000101297520000835
Q2 2020 125 6,161,156 FOLD, GBT, RETROPHIN INC, IOVA RESTATEMENT 8/17/2020 000101297520000701
Q1 2020 113 3,838,520 IOVA, GBT, NBIX, MRTX RESTATEMENT 5/18/2020 000101297520000472
Q4 2019 114 5,003,206 GBT, MRTX, NBIX, KOD RESTATEMENT 2/19/2020 000101297520000250
Q3 2019 109 3,705,967 NBIX, GBT, MRTX, IOVA 13F-HR 11/14/2019 000101297519000707
Q2 2019 104 4,357,842 NBIX, GBT, MRTX, IOVA 13F-HR 8/14/2019 000101297519000583
Q1 2019 105 3,542,095 NBIX, FOLD, GBT, ZGNX RESTATEMENT 5/16/2019 000101297519000380
Q4 2018 101 2,626,846 NBIX, GBT, FOLD, ZGNX 13F-HR 2/14/2019 000101297519000177
Q3 2018 117 3,736,100 NBIX, FOLD, GBT, ZGNX 13F-HR 11/14/2018 000101297518001239
Q2 2018 125 3,814,393 NBIX, FOLD, GBT, ALNY RESTATEMENT 11/1/2018 000101297518001190
Q1 2018 137 3,556,351 NBIX, FOLD, GBT, ZGNX 13F-HR 5/15/2018 000101297518000425
Q4 2017 132 3,016,032 NBIX, FOLD, GBT, ALNY 13F-HR 2/14/2018 000101297518000171
Q3 2017 139 2,611,506 NBIX, FOLD, ALNY, GBT RESTATEMENT 11/14/2017 000101297517000846
Q2 2017 126 1,931,454 FOLD, NBIX, ALNY, GBT 13F-HR 8/14/2017 000101297517000624
Q1 2017 173 1,751,333 NBIX, GBT, FOLD, VSAR 13F-HR 5/15/2017 000101905617000467
Q4 2016 198 1,403,683 NBIX, TSRO, FOLD, SRPT RESTATEMENT 5/2/2017 000101905617000406
Q3 2016 196 1,538,535 SRPT, NBIX, FOLD, TSRO 13F-HR 11/14/2016 000101905616001648
Q2 2016 173 1,229,094 SRPT puts, NBIX, TSRO, FOLD 13F-HR 8/11/2016 000101905616001477
Q1 2016 170 1,108,880 FOLD, NBIX, SRPT, TSRO 13F-HR 5/16/2016 000101905616001336
Q4 2015 155 1,296,888 FOLD, NBIX, SRPT, DYAX 13F-HR 2/16/2016 000101905616001109
Q3 2015 158 1,094,835 FOLD, NBIX, SRPT, RTRX NEW HOLDINGS 11/17/2015 000101905615000911
Q2 2015 173 1,533,778 FOLD, NBIX, RTRX, SRPT 13F-HR 8/14/2015 000101905615000685
Q1 2015 158 1,247,553 FOLD, NBIX, RTRX, TSRO 13F-HR 5/15/2015 000101905615000506
Q4 2014 150 1,116,941 FOLD, NBIX, ACRX, SRPT 13F-HR 2/17/2015 000101905615000222
Q3 2014 125 918,490 FOLD, NBIX, AFMD, SRPT RESTATEMENT 11/17/2014 000101905614001426
Q2 2014 117 998,847 SRPT, NBIX, ACRX, VRTX 13F-HR 8/14/2014 000101905614001053
Q1 2014 127 891,336 ACRX, NBIX, SRPT, VRTX 13F-HR 5/15/2014 000101905614000699
Q4 2013 110 808,819 CELG, ACRX, SRPT, VRTX 13F-HR 2/14/2014 000101905614000254
Additional filings from Perceptive Advisors LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Trinity Biotech plc 13D/A
TRIB · 896438603
10.0% 11/10/2026
Event 11/6/2026
LeonaBio, Inc. 13D/A
LONA · 04746L203
20.0% 10/26/2026
Event 10/26/2026
Kardigan, Inc. 13D/A
KARD · 485925101
8.8% 10/1/2026
Event 9/29/2026
Immatics N.V. 13D/A
IMTX · N44445109
7.6% 8/27/2026
Event 8/26/2026
Solid Biosciences Inc. 13D/A
SLDB · 83422E204
11.2% 8/14/2026
Event 6/30/2026
Trinity Biotech plc 13D/A
TRIB · 896438504
9.9% 5/4/2026
Event 4/30/2026
MeiraGTx Holdings plc 13D/A
MGTX · G59665102
12.6% 4/24/2026
Event 4/17/2026
Lyra Therapeutics, Inc. 13D/A
LYRA · 55234L105
15.6% 8/14/2025
Event 8/12/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Nautilus Biotechnology, Inc. 13D/A
NAUT · 63909J108
3.9% 11/3/2026
Event 10/5/2026
Astria Therapeutics, Inc. 13D/A
ATXS · 04635X102
0% 2/9/2026
Event 1/26/2026
Lyra Therapeutics, Inc. 13D/A
LYRA · 55234L204
0% 11/25/2025
Event 11/21/2025

66 other securities where the latest filing is a 13G, the newest filed 11/16/2026. View all